Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK

Chinese Journal of Cancer

Volumn 29, Issue 7, 2010, Pages 641-648

  Wang, Qi Jing ^a   Wang, Hui ^a   Pan, Ke ^a   Li, Yong Qiang ^a   Huang, Li Xi ^a   Chen, Shi Ping ^a   He, Jia ^a   Ke, Miao La ^a   Zhao, Jing Jing ^a   Li, Jian Jun ^a   Sun, Jian Cong ^a   Liang, Xiao Ting ^a   Ma, Hai Qing ^a   Chen, Yi Bing ^a   Xia, Jian Chuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Cytokine induced killer cells; Dendritic cells; Immunotherapy; Semi allogeneic DC CIK cells

Indexed keywords

6 CARBOXYFLUORESCEIN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; LACTATE DEHYDROGENASE; LIPOCORTIN 5;

ADOPTIVE IMMUNOTHERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOKINE RELEASE; CYTOTOXICITY TEST; DENDRITIC CELL; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; LUNG CANCER; MAXILLA SINUS CARCINOMA; PHENOTYPE; SQUAMOUS CELL CARCINOMA; TUMOR IMMUNITY;

EID: 79955866235     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10772     Document Type: Article

References (26)

1. Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity [J]. J Exp Med, 1991, 174 (1): 139-149.
2. Azuma E, Masuda S, Qi J, et al. Cytotoxic T-lymphocytes recognizing P-glycoprotein in murine multidrug-resistant leukemias [J]. Eur J Haematol, 1997, 59(1): 14-19.
3. + T cells to Fas-mediated apoptosis [J]. Cancer Immunol Immunother, 2000, 49(6): 335-345.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity [J]. Nature, 1998, 392(6673): 245-252.
5. Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations [J]. J Immunother, 2001, 24(6): 502-510.
6. + cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells [J]. Int J Hematol, 2003, 77(2): 175-179.
7. Wang H, Zhou FJ, Wang QJ, et al. Efficacy of autologous renal tumor cell lysate-lo aded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma-a report of ten cases [J]. Chin J Cancer, 2006, 25(5): 625-630. [in Chinese]
8. Gabrilovich DI, Corak J, Ciernik IF, et al. Decreased antigen presentation by dendritic cells in patients with breast cancer [J]. Clin Cancer Res, 1997, 3(3): 483-490.
9. Jomantaite I, Dikopoulos N, Kroger A, et al. Hepatic dendritic cell subsets in the mouse [J]. Eur J Immunol, 2004, 34(2): 355-365.
10. Zoll B, Lefterova P, Ebert O, et al. Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation [J]. Cytokine, 2000, 12(9): 1385-1390.
11. Almand B, Clark JI, Nikitina E, et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer [J]. J Immunol, 2001, 166(1): 678-689.
12. Laurin D, Kanitakis J, Bienvenu J, et al. Allogeneic reaction induces dendritic cell maturation through proinflammatory cytokine secretion [J]. Transplantation, 2004, 77(2): 267-275.
13. Burrows SR, Khanna R, Burrows JM, et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease [J]. J Exp Med, 1994, 179(4): 1155-1161.
14. Chewning JH, Gudme CN, Hsu KC, et al. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro [J]. J Immunol, 2007, 179(2): 854-868.
15. Danzer SG, Kirchner H, Rink L. Cytokine interactions in human mixed lymphocyte culture [J]. Transplantation, 1994, 57(11): 1638-1642.
16. + cytotoxic T-lymphocytes in vitro using allogeneic dendritic cells [J]. Cell Transplant, 1998, 7(1): 1-9.
17. + regulatory T cells by dendritic cells during the mixed leukocyte reaction [J]. Proc Natl Acad Sci U S A, 2006, 103(8): 2758-2763.
18. Avigan DE, Vasir B, George DJ, et al. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma [J]. J Immunother, 2007, 30(7): 749-761.
19. Barbuto JA, Ensina LF, Neves AR, et al. Dendritic cell-tumor cell hybrid vaccination for metastatic cancer [J]. Cancer Immunol Immunother, 2004, 53(12): 1111-1118.
20. Bird RC, Deinnocentes P, Lenz S, et al. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer [J]. Vet Immunol Immunopathol, 2008, 123(3-4): 289-304.
21. de Gruijl TD, van den Eertwegh AJ, Pinedo HM, et al. Whole-cell cancer vaccination: from autologous to allogeneic tumor-and dendritic cell-based vaccines [J]. Cancer Immunol Immunother, 2008, 57(10): 1569-1577.
22. Yasuda T, Kamigaki T, Kawasaki K, et al. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma [J]. Cancer Immunol Immunother, 2007, 56(7): 1025-1036.
23. Wells JW, Cowled CJ, Darling D, et al. Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity [J]. Cancer Immunol Immunother, 2007, 56(12): 1861-1873.
24. Yang G, Tan J, Wei G, et al. Effects of ex vivo activated immune cells on syngeneic and semi-allogeneic bone marrow transplantation in mice [J]. Transpl Immunol, 2006, 16(3-4): 166-171.
25. Fukuma D, Matsuyoshi H, Hirata S, et al. Cancer prevention with semi-allogeneic ES cell-derived dendritic cells [J]. Biochem Biophys Res Commun, 2005, 335(1): 5-13.
26. Beschorner WE, Yao X, Divic J. Recruitment of semiallogeneic dendritic cells to the thymus during post-cyclosporine thymic regeneration [J]. Transplantation, 1995, 60(11): 1326-1330.